SKN | Rare Disease Biotech Polaryx Therapeutics Files for a Direct Listing on the Nasdaq
Polaryx Therapeutics, a rare disease-focused biotechnology company, has filed for a direct listing on the Nasdaq, signaling its intent to access public capital without...
SKN | New Fortress Energy (NFE) Eyes Strategic IPO Raise to Expand Global LNG Infrastructure
New Fortress Energy Inc., a global gas-to-power infrastructure company, is preparing a new capital-raising IPO initiative aimed at accelerating its expansion across international LNG...
SKN | Central Bancompany Prices Nasdaq Uplisting at $21 in a $373 Million Offering
Central Bancompany, a Missouri-based regional banking powerhouse, has priced its long-anticipated Nasdaq uplisting at $21 per share, the low end of its proposed range....
SKN | Chinese Zipper Producer Fuxing China Group Withdraws $8 Million IPO
Fuxing China Group, a long-established Chinese manufacturer of zippers and fastening products, has withdrawn its planned $8 million U.S. IPO, halting what would have...
SKN | Exact Sciences Corporation Plans $1 Billion Follow-On Offering to Accelerate Cancer Screening and Diagnostics Expansion
Exact Sciences Corporation (EXAS), a global leader in cancer detection and diagnostics, has announced plans for a $1 billion follow-on public offering to strengthen...